Allergan says no to Valeant…which comes back with a better offer

 

The Board of Directors at Allergan, the manufacturer of Restasis eye drops, formally rejected the unsolicited takeover bid from Quebec-based Valeant Pharmaceuticals.

 

Allergan says that the $52-billion offer in cash and stock undervalues the company and does not reflect its potential for growth. The Board has targeted a 20% to 25% increase in its earnings per share and expects a strong increase in revenue in 2015.

 

In a letter sent to his counterpart at Valeant, the CEO of Allergan also questioned how Valeant would achieve the level of cost cuts it is proposing without harming the long-term viability of Allergan. Valeant estimates that the acquisition will generate $3.3 billion in operating cost savings as a result of synergies.

 

Far from giving up, Valeant quickly responded, stating that the offer would be increased. The details are to be announced May 28. Furthermore, Pershing Square Capital Management, Valeant’s partner in this purchase offer, hopes to obtain the complete list of Allergan’s shareholders. Valeant would like to organize a “referendum” to determine whether shareholders want to see the two companies negotiate the merger. Valeant could even ask for a special meeting to be held to replace some or all of Allergan’s Board members.


Sources:

http://www.lesaffaires.com/secteurs-d-activite/sante-pharmaceutique-et-biotechnologies/allergan-rejette-l-offre-de-valeant/568801

http://eyewiretoday.com/view.asp?20140512-allergan_rejects_valeant_pharmas_cut_and_slash_takeover

Featured Posts

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read More

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read More

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read More

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read More

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more

Flirty Cat-Eye Sunnies from OTPS are Totally Trending

OTPS-2031’s Rose Tortoise is a fun and flirty frame created using colourful patterned biodegradable acetate.

Learn More

25,700+ Accept WCO Myopia Management Standard of Care Pledge Challenge

Global Organizations and Eye Care Professionals Pledge to Embrace the Three Pillars of Myopia Management

Read more

February is AMD Awareness Month Recognizing the Leading Cause of Vision Loss in Seniors

Fighting Blindness Canada (FBC) is marking Age-Related Macular Degeneration (AMD) Awareness Month with activities to inform and educate Canadians about the leading cause of vision loss in people over the age of 55, impacting approximately 2.5 million Canadians.

Read more

MIDO 2023 is Ready: All Eyes on the International Eyewear Show

Appointment with MIDO at Fiera Milano Rho Saturday, February 4 to Monday, February 6

Read more

February is IRIS Mundial Month for Sixteenth Year

IRIS Mundial announces that, for a 16th year, the organization will benefit from an annual fundraising campaign organized by IRIS, The Visual Group, its main partner.

Read more